Literature DB >> 6534427

Cancer of the prostate. Do younger men have a poorer survival rate?

J M Wilson, I W Kemp, G J Stein.   

Abstract

Analysis of cancer registration survival data, together with a review of published clinical and pathological studies, strongly suggests that cancer of the prostate occurring before the age of 55 has a worse survival prospect than at ages up to 74. The likely reasons appear to be a higher degree of malignancy of tumours in younger men and, particularly, late diagnosis from failure to suspect the disease in this age group. This suggests that routine clinical examination of the prostate should be carried out as soon as feasible after the age of 40.

Entities:  

Mesh:

Year:  1984        PMID: 6534427     DOI: 10.1111/j.1464-410x.1984.tb05828.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  5 in total

1.  Prostate Cancer: How Young is too Young?

Authors:  Sahil Gupta; Arjun Gupta; Ashish K Saini; Kaustav Majumder; Kalpana Sinha; Anurag Chahal
Journal:  Curr Urol       Date:  2016-12-26

Review 2.  Prostate cancer in young men: an important clinical entity.

Authors:  Claudia A Salinas; Alex Tsodikov; Miriam Ishak-Howard; Kathleen A Cooney
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

3.  microRNA Expression Profiling in Young Prostate Cancer Patients.

Authors:  Vladimir A Valera; Rafael Parra-Medina; Beatriz A Walter; Peter Pinto; Maria J Merino
Journal:  J Cancer       Date:  2020-04-07       Impact factor: 4.207

4.  Measures of mortality in prostatic cancer.

Authors:  C M Goodman; A W Ritchie; G D Chisholm
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

5.  Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta-analysis.

Authors:  Yu Zheng; Sharron X Lin; Shulin Wu; Douglas M Dahl; Michael L Blute; Wei-De Zhong; Xing Zhou; Chin-Lee Wu
Journal:  Cancer Med       Date:  2020-07-22       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.